The Penn State Mcnair Journal
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The Debs Case: Labor, Capital, and the Federal Courts of the 1890S By
The Debs Case: Labor, Capital, and the Federal Courts of the 1890s by David Ray Papke, Professor of Law Marquette University Law School Revised by the Federal Judicial Center for inclusion in the project Federal Trials and Great Debates in United States History Federal Judicial Center Federal Judicial History Offi ce 2008 This Federal Judicial Center publication was undertaken in furtherance of the Centerʼs statutory mission to “conduct, coordinate, and encourage programs relating to the history of the judicial branch of the United States government.” The views expressed are those of the author and not necessarily those of the Federal Judicial Center. The Debs Case: Labor, Capital, and the Federal Courts of the 1890s Contents The Debs Case: A Short Narrative, 1 The town of Pullman, 1 A strike and boycott, 2 Management organizes, 3 Federal response, 4 A petition to the Supreme Court of the United States, 6 The Federal Courts and Their Jurisdiction, 9 U.S. Circuit Court for the Northern District of Illinois, 9 U.S. District Court for the Northern District of Illinois, 9 Supreme Court of the United States, 10 The Judicial Process: A Chronology, 11 Legal Questions Before the Courts, 13 Did the U.S. Circuit Court for the Northern District of Illinois have authority to issue an injunction against Eugene V. Debs and the offi cers of the American Railway Union? 13 Did the Sherman Anti-Trust Act of 1890 apply to labor unions as well as trusts and monopolies? 14 Did Eugene V. Debs and the other offi cers of the American Railway Union violate the injunction? 14 Did the U.S. -
Us 2018 / 0296525 A1
UN US 20180296525A1 ( 19) United States (12 ) Patent Application Publication (10 ) Pub. No. : US 2018/ 0296525 A1 ROIZMAN et al. ( 43 ) Pub . Date: Oct. 18 , 2018 ( 54 ) TREATMENT OF AGE - RELATED MACULAR A61K 38 /1709 ( 2013 .01 ) ; A61K 38 / 1866 DEGENERATION AND OTHER EYE (2013 . 01 ) ; A61K 31/ 40 ( 2013 .01 ) DISEASES WITH ONE OR MORE THERAPEUTIC AGENTS (71 ) Applicant: MacRegen , Inc ., San Jose , CA (US ) (57 ) ABSTRACT ( 72 ) Inventors : Keith ROIZMAN , San Jose , CA (US ) ; The present disclosure provides therapeutic agents for the Martin RUDOLF , Luebeck (DE ) treatment of age - related macular degeneration ( AMD ) and other eye disorders. One or more therapeutic agents can be (21 ) Appl. No .: 15 /910 , 992 used to treat any stages ( including the early , intermediate ( 22 ) Filed : Mar. 2 , 2018 and advance stages ) of AMD , and any phenotypes of AMD , including geographic atrophy ( including non -central GA and Related U . S . Application Data central GA ) and neovascularization ( including types 1 , 2 and 3 NV ) . In certain embodiments , an anti - dyslipidemic agent ( 60 ) Provisional application No . 62/ 467 ,073 , filed on Mar . ( e . g . , an apolipoprotein mimetic and / or a statin ) is used 3 , 2017 . alone to treat or slow the progression of atrophic AMD Publication Classification ( including early AMD and intermediate AMD ) , and / or to (51 ) Int. CI. prevent or delay the onset of AMD , advanced AMD and /or A61K 31/ 366 ( 2006 . 01 ) neovascular AMD . In further embodiments , two or more A61P 27 /02 ( 2006 .01 ) therapeutic agents ( e . g ., any combinations of an anti - dys A61K 9 / 00 ( 2006 . 01 ) lipidemic agent, an antioxidant, an anti- inflammatory agent, A61K 31 / 40 ( 2006 .01 ) a complement inhibitor, a neuroprotector and an anti - angio A61K 45 / 06 ( 2006 .01 ) genic agent ) that target multiple underlying factors of AMD A61K 38 / 17 ( 2006 .01 ) ( e . -
Table of Contents
U.S. Court Cases Editor:Thomas Tandy Lewis, St. Cloud State Univ. August 2010 · 3 volumes · 1,346 pages · 6"x 9" ISBN: 978-1-58765-672-9 List Price: $225 e-ISBN: 978-1-58765-676-7 eBook Single User Price: $225 Table of Contents Volume 1 Contents Publisher’s Note Contributors U.S. Supreme Court Citation Numbers Law and the Courts Anglo-American Legal Systems Law Jurisprudence The U.S. Constitution The Bill of Rights Constitutional Law The U.S. Judicial System State and Local Courts The U.S. Supreme Court Judicial Review Due Process of Law Court Cases Abington School District v. Schempp Ableman v. Booth Abrams v. United States Adair v. United States Adamson v. California Adarand Constructors v. Peña Adderley v. Florida Adkins v. Children’s Hospital Afroyim v. Rusk Agostini v. Felton Akron v. Akron Center for Reproductive Health Albemarle Paper Co. v. Moody Albertson v. Subversive Activities Control Board Alcoa v. Federal Trade Commission Alexander v. Holmes County Board of Education Allegheny County v. American Civil Liberties Union Greater Pittsburgh Chapter Allgeyer v. Louisiana Alsager v. District Court American Booksellers Association, Inc. v. Hudnut American Communications Association v. Douds Antelope, The Aptheker v. Secretary of State Argersinger v. Hamlin Arizona v. Fulminante Arlington Heights v. Metropolitan Housing Development Corp. Ashcroft v. Free Speech Coalition Ashwander v. Tennessee Valley Authority Atkins v. Virginia Atwater v. City of Lago Vista Automobile Workers v. Johnson Controls Bailey v. Drexel Furniture Co. Baker v. Carr Baker v. Vermont Ballard v. United States Ballew v. Georgia Bank of Augusta v. -
Abington School District V. Schempp 1 Ableman V. Booth 1 Abortion 2
TABLE OF CONTENTS VOLUME 1 Bill of Rights 66 Birth Control and Contraception 71 Abington School District v. Schempp 1 Hugo L. Black 73 Ableman v. Booth 1 Harry A. Blackmun 75 Abortion 2 John Blair, Jr. 77 Adamson v. California 8 Samuel Blatchford 78 Adarand Constructors v. Peña 8 Board of Education of Oklahoma City v. Dowell 79 Adkins v. Children’s Hospital 10 Bob Jones University v. United States 80 Adoptive Couple v. Baby Girl 13 Boerne v. Flores 81 Advisory Opinions 15 Bolling v. Sharpe 81 Affirmative Action 15 Bond v. United States 82 Afroyim v. Rusk 21 Boumediene v. Bush 83 Age Discrimination 22 Bowers v. Hardwick 84 Samuel A. Alito, Jr. 24 Boyd v. United States 86 Allgeyer v. Louisiana 26 Boy Scouts of America v. Dale 86 Americans with Disabilities Act 27 Joseph P. Bradley 87 Antitrust Law 29 Bradwell v. Illinois 89 Appellate Jurisdiction 33 Louis D. Brandeis 90 Argersinger v. Hamlin 36 Brandenburg v. Ohio 92 Arizona v. United States 36 William J. Brennan, Jr. 92 Arlington Heights v. Metropolitan Housing David J. Brewer 96 Development Corporation 37 Stephen G. Breyer 97 Ashcroft v. Free Speech Coalition 38 Briefs 99 Ashwander v. Tennessee Valley Authority 38 Bronson v. Kinzie 101 Assembly and Association, Freedom of 39 Henry B. Brown 101 Arizona v. Gant 42 Brown v. Board of Education 102 Atkins v. Virginia 43 Brown v. Entertainment Merchants Association 104 Automobile Searches 45 Brown v. Maryland 106 Brown v. Mississippi 106 Bad Tendency Test 46 Brushaber v. Union Pacific Railroad Company 107 Bail 47 Buchanan v. -
Integrative and Systemic Approaches for Evaluating Pparβ/Δ (PPARD)
Integrative and systemic approaches for evaluating PPAR β/δ (PPARD) function Greta MP Giordano Attianese and Béatrice Desvergne Center for Integrative Genomics, University of Lausanne, Switzerland Footnotes: Corresponding author, BD: [email protected] Competing interests: The authors declare no competing financial interests Author contributions: Both authors have been involved in drafting the manuscript and revising it critically. Received December 5, 2014; Accepted March 9, 2015; Published April 27, 2015 Copyright © 2015 Giordano Attianese and Desvergne. This is an open-access article distributed under the terms of the Creative Commons Non-Commercial Attribution License, which permits unrestricted non-commercial use distribution and reproduction in any medium, provided the original work is properly cited. Abbreviations: αMyHC, α-Myosin Heavy Chain; BCL6, B-cell lymphoma 6 protein; BAT, Brown adipose tissue; ChIP, Chromatin Immunoprecipitation; CHD, Coronary heart disease; DBD, DNA-binding domain; FAO, Fatty Acid Oxidation; FA, Fatty Acid; GSIS, Glucose-stimulated insulin secretion; HSC, Hematopoietic Stem cells; H&E, Hematoxylin and Eosin; HDAC1, Histone deacetylase 1; LBD, Ligand binding domain; MCP1, Monocyte chemotactic protein 1; NFkB, Nuclear factor kappa-light-chain- enhancer of activated B cells; NR, Nuclear Receptor; NCoR1, Nuclear receptor co-repressor 1; PPARs, Peroxisome proliferator- activated receptors; PPRE, PPAR-responsive element; RER, Respiratory Exchange Ratio; RA, Retinoic Acid; RXR, Retinoid X receptor; SMRT, Silencing mediator of retinoic acid and thyroid hormone receptors; SNPs, Single Nucleotide Polymorphisms; SUMO, Small Ubiquitin-like Modifier; TZDs, Thiazolidinediones; TR, Thyroid hormone receptor; TG, Triglycerides; VLDL, Very large density lipoprotein; WOSCOPS, West of Scotland Coronary Prevention Study; WAT, White adipose tissue. Citation: Giordano Attianese G and Desvergne B (2015) Integrative and systemic approaches for evaluating PPAR β/δ (PPARD) function. -
Standing Outside of Article Iii
UNIVERSITY of PENNSYLVANIA LAW REVIEW Founded 1852 Formerly AMERICAN LAW REGISTER © 2014 by the University of Pennsylvania Law Review VOL. 162 MAY 2014 NO. 6 ARTICLE STANDING OUTSIDE OF ARTICLE III TARA LEIGH GROVE† The U.S. Supreme Court has insisted that standing doctrine is a “bedrock” re- quirement only of Article III. Accordingly, both jurists and scholars have assumed † Associate Professor, William and Mary Law School. I am grateful to Randy Barnett, Amy Barrett, A.J. Bellia, Neal Devins, Dave Douglas, Richard Fallon, Josh Fischman, David Fontana, Barry Friedman, Amanda Frost, Mark Graber, Chris Griffin, Aziz Huq, Vicki Jackson, Alli Larsen, Kurt Lash, Gary Lawson, Daryl Levinson, John Manning, Alan Meese, Gillian Metzger, Henry Monaghan, Nate Oman, Jim Pfander, Marty Redish, Judith Resnik, Mark Seidenfeld, David Shapiro, Suzanna Sherry, Larry Solum, Kevin Stack, Carlos Vazquez, Steve Vladeck, Tobias Wolff, Ann Woolhandler, Ingrid Wuerth,Ernie Young, and Tim Zick for discussions of this project or comments on earlier drafts. I am also grateful to Dara Gibson, Amanda Hamm, Alexis Patillo, and Alex Reidell for helpful research assistance. This Article was selected for presentation at the 2014 New Voices in Civil Justice Workshop at Vanderbilt Law School, the Sixth Annual Junior Faculty Federal Courts Workshop at Brooklyn Law School, and the Fourth Annual Constitutional Law Colloquium at Loyola University Chicago School of Law. The Article was also presented at the Georgetown University Law Center Constitutional Law Colloquium, Florida State University College of Law, William and Mary Law School, and American Universi- ty Washington College of Law. I am grateful for comments and suggestions offered at those events. -
The Constitution in the Supreme Court: the Protection of Economic Interests, 1889-1910
University of Chicago Law School Chicago Unbound Journal Articles Faculty Scholarship 1985 The Constitution in the Supreme Court: The Protection of Economic Interests, 1889-1910 David P. Currie Follow this and additional works at: https://chicagounbound.uchicago.edu/journal_articles Part of the Law Commons Recommended Citation David P. Currie, "The Constitution in the Supreme Court: The Protection of Economic Interests, 1889-1910," 52 University of Chicago Law Review 324 (1985). This Article is brought to you for free and open access by the Faculty Scholarship at Chicago Unbound. It has been accepted for inclusion in Journal Articles by an authorized administrator of Chicago Unbound. For more information, please contact [email protected]. The Constitution in the Supreme Court: The Protection of Economic Interests, 1889-1910 David P. Curriet The Supreme Court's first hundred years virtually ended with the death of Chief Justice Morrison R. Waite in March 1888. Five of Waite's brethren-Stanley Matthews, Samuel F. Miller, Joseph P. Bradley, Samuel Blatchford, and Lucius Q.C. Lamar-left the Court within the next five years, and a sixth-Stephen J. Field-hung on after his powers had faded.1 By 1894, Melville W. Fuller2 presided over an essentially new Court consisting of David J. Brewer, Henry B. Brown, George Shiras, Howell E. Jackson, and Edward Douglass White3 in addition to the three holdovers, John M. Harlan, Horace Gray, and Field. Jackson and Field soon gave way to Rufus W. Peckham and Joseph McKenna; Gray and Shiras, after the turn of the century, were replaced by Oliver Wendell Holmes and William R. -
The Constitution in the Supreme Court: the Protection of Economic Interests, 1889-1910 David P
The Constitution in the Supreme Court: The Protection of Economic Interests, 1889-1910 David P. Curriet The Supreme Court's first hundred years virtually ended with the death of Chief Justice Morrison R. Waite in March 1888. Five of Waite's brethren-Stanley Matthews, Samuel F. Miller, Joseph P. Bradley, Samuel Blatchford, and Lucius Q.C. Lamar-left the Court within the next five years, and a sixth-Stephen J. Field-hung on after his powers had faded.1 By 1894, Melville W. Fuller2 presided over an essentially new Court consisting of David J. Brewer, Henry B. Brown, George Shiras, Howell E. Jackson, and Edward Douglass White3 in addition to the three holdovers, John M. Harlan, Horace Gray, and Field. Jackson and Field soon gave way to Rufus W. Peckham and Joseph McKenna; Gray and Shiras, after the turn of the century, were replaced by Oliver Wendell Holmes and William R. Day. William H. Moody and Horace R. Lurton served briefly at the end of Fuller's term, and another mas- sive turnover accompanied Fuller's death in 1910. Thus the per- sonnel of Fuller's twenty-one-year tenure is well separated from that of the preceding and following periods. Moreover, although twenty Justices sat during this time, eleven did the lion's share of the work: Harlan, Gray, Fuller, Brewer, Brown, Shiras, White, t Harry N. Wyatt Professor of Law, University of Chicago. I thank Karla Kraus and Richard Levy for valuable research assistance, Mitchell Daffner for taming the computer, Richard Helmholz, Richard Posner, and Cass R. Sunstein for helpful comments, and the Jerome S. -
Development of Novel Synthetic Routes to the Epoxyketooctadecanoic Acids
DEVELOPMENT OF NOVEL SYNTHETIC ROUTES TO THE EPOXYKETOOCTADECANOIC ACIDS (EKODES) AND THEIR BIOLOGICAL EVALUATION AS ACTIVATORS OF THE PPAR FAMILY OF NUCLEAR RECEPTORS By ROOZBEH ESKANDARI Submitted in partial fulfillment of the requirements for The Degree of Doctor of Philosophy Thesis Advisor: Gregory P. Tochtrop, Ph.D. Department of Chemistry CASE WESTERN RESERVE UNIVERSITY January, 2016 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the thesis/dissertation of ROOZBEH ESKANDARI Candidate for the Ph.D degree *. (signed) Anthony J. Pearson, PhD (Chair of the committee) Gregory P. Tochtrop, PhD (Advisor) Michael G. Zagorski, PhD Blanton S. Tolbert, PhD Witold K. Surewicz, PhD (Department of Physiology and Biophysics) (date) 14th July, 2015 *We also certify that written approval has been obtained for any proprietary material contained therein. I dedicate this work to my sister Table of Contents Table of Contents ........................................................................................................................ i List of Tables .............................................................................................................................. vi List of Figures ........................................................................................................................... vii List of Schemes .......................................................................................................................... ix Acknowledgements .................................................................................................................. -
Cellular and Pharmacological Selectivity of the Peroxisome Proliferator-Activated Receptor-ß/Δ Antagonist GSK3787
0026-895X/10/7803-419–430 MOLECULAR PHARMACOLOGY Vol. 78, No. 3 U.S. Government work not protected by U.S. copyright 65508/3613101 Mol Pharmacol 78:419–430, 2010 Printed in U.S.A. Cellular and Pharmacological Selectivity of the Peroxisome Proliferator-Activated Receptor-/␦ Antagonist GSK3787□S Prajakta S. Palkar, Michael G. Borland, Simone Naruhn, Christina H. Ferry, Christina Lee, Ugir H. Sk, Arun K. Sharma, Shantu Amin, Iain A. Murray, Cherie R. Anderson, Gary H. Perdew, Frank J. Gonzalez, Rolf Mu¨ ller, and Jeffrey M. Peters Department of Veterinary and Biomedical Sciences and the Center for Molecular Toxicology and Carcinogenesis, the Pennsylvania State University, University Park, Pennsylvania (P.S.P., M.G.B., C.H.F., C.L., I.A.M., C.R.A., G.H.P., J.M.P.); Institute of Molecular Biology and Tumor Research, Philipps University, Marburg, Germany (S.N., R.M.); Department of Pharmacology, Penn State Hershey Cancer Institute, the Pennsylvania State University, Milton S. Hershey Medical Center, Hershey, Pennsylvania (A.K.S., U.H.S., S.A.); and Laboratory of Metabolism, National Cancer Institute, Bethesda, Maryland (F.J. G.) Received April 9, 2010; accepted June 1, 2010 ABSTRACT The availability of high-affinity agonists for peroxisome prolifera- PPAR␣ activity. Time-resolved fluorescence resonance energy tor-activated receptor-/␦ (PPAR/␦) has led to significant ad- transfer assays confirmed the ability of GSK3787 to modulate the vances in our understanding of the functional role of PPAR/␦.In association of both PPAR/␦ and PPAR␥ coregulator peptides in this study, a new PPAR/␦ antagonist, 4-chloro-N-(2-{[5-tri- response to ligand activation, consistent with reporter assays. -
The History and Principles of American Copyright Protection for Fashion Design: a Strange Centennial
\\jciprod01\productn\H\HLS\6-2\HLS201.txt unknown Seq: 1 6-NOV-15 7:40 The History and Principles of American Copyright Protection for Fashion Design: A Strange Centennial Charles E. Colman* Series Preface Between 1914 and 1916, the United States Congress saw the first seri- ous round of lobbying by advocates seeking more robust legal protection of original industrial design and applied art, including fashion design. In the subsequent hundred years, the fashion industry has become a powerful (if fractured) force on the American legislative scene—yet fashion designers and their allies have continually failed to persuade Congress to amend federal statutes to provide greater rights in the appearance of their creations. At the same time, these stakeholders have pressed their cause in the courts, with varying results. This series of articles examines the U.S. federal courts’ adju- dication of the resulting disputes. In the process, the articles to come will highlight tacit assumptions, unacknowledged inconsistencies, and irrecon- cilable tensions in the case law. At the same time, this series will seek to shed light on largely unrecognized consistencies, coherent but under-theo- rized quasi-doctrines, and systematic principles that characterize—and, in many instances, are arguably unique to—U.S. “copyright-for-fashion” jurisprudence. Before embarking on this journey, it is necessary as an initial matter to dispose of the commonly recited myth that there is “no copyright for fash- ion” under U.S. law. In fact, certain components of fashion design receive * Acting Assistant Professor, NYU School of Law. © 2015 Charles E. Colman. I would like to thank Francis Galasi, Rachael Griffith-Pierce, Yin Huang, Guillermo Jimenez, Barbara Kolsun, Angela Lelo, Ariana Lo Giudice, Hannah Mrakovich, Sam Van Eichner, and the editors and staff of the Harvard Journal of Sports and Entertainment Law (especially Jeff Huberman, Marissa Lambert, and Sam Stuckey.) \\jciprod01\productn\H\HLS\6-2\HLS201.txt unknown Seq: 2 6-NOV-15 7:40 226 Harvard Journal of Sports & Entertainment Law / Vol. -
A2E Induces the Transactivation of Rars, Ppars and Rxrs and Its Effects Are Counteracted by Norbixin in Retinal Pigment Epithelium Cells in Vitro
bioRxiv preprint doi: https://doi.org/10.1101/2020.03.30.016071; this version posted April 1, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. A2E induces the transactivation of RARs, PPARs and RXRs and its effects are counteracted by norbixin in retinal pigment epithelium cells in vitro Valérie Fontaine1 *, Mylène Fournié1, Elodie Monteiro1, Thinhinane Boumedine1, Christine Balducci2, Louis Guibout2, Mathilde Latil2, Pierre J. Dilda2, José-Alain Sahel1,3,4, Stanislas Veillet2, René Lafont2, Serge Camelo2 1 Sorbonne Université, INSERM, CNRS, Institut de la Vision, 17 Rue Moreau, F-75012 Paris, France 2 Biophytis, Sorbonne Université, BC9, 4 place Jussieu, 75005 Paris, France 3 CHNO des Quinze-Vingts, DHU Sight Restore, INSERM-DGOS CIC 1423, 28 rue de Charenton, F- 75012, Paris, France 4 Department of Ophthalmology, The University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA *Corresponding author: Valérie Fontaine Email: [email protected] Running Title: Norbixin modulates NRs activation by A2E in RPE cells Keywords: N-retinylidene-N-retinylethanolamine (A2E), angiogenesis, apoptosis, inflammation, norbixin, nuclear receptor (NR), peroxisome proliferator-activated receptor (PPAR), retinoic acid receptor (RAR), retinal pigment epithelium (RPE), retinoic X receptor (RXR) ABSTRACT transactivation induced by A2E. Norbixin also N-retinylidene-N-retinylethanolamine (A2E) inhibits PPAR-g transactivation induced by its plays a central role in age-related macular high affinity ligand troglitazone. degeneration (AMD) by inducing apoptosis, Photoprotection of RPE cells by norbixin angiogenesis and inflammation. It has been correlates with maintained levels of the proposed that A2E effects are mediated at least antiapoptotic B-cell lymphoma 2 (Bcl2) partly via the retinoic acid receptor (RAR)-a.